What Are The Strategic Insights Behind The Dry Age Related Macular Degeneration (AMD) Market Expansion To $6.8 Billion?
Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
What Is The Current Size And Growth Outlook For The Dry Age Related Macular Degeneration (AMD) Market?
Over the past years, the market size for dry age related macular degeneration (amd) has shown significant growth. A prediction has been made that an expansion from $4.49 billion in 2024 to $4.89 billion in 2025 will occur, representing a compound annual growth rate (CAGR) of 8.8%. The growth observed during historical periods can be linked to factors such as an increasing elderly population, higher instances of chronic diseases, an increase in awareness around eye health, the rise in clinical trials dedicated to dry AMD, and heightened demand for treatments that are minimally invasive.
In the coming years, the market for dry age-related macular degeneration (amd) is predicted to experience substantial growth, escalating to $6.8 billion by 2029, with a compound annual growth rate (CAGR) of 8.6%. This projected expansion is driven by factors such as the introduction of novel therapies, increased spending on healthcare, more frequent use of laser photocoagulation therapy, breakthroughs in genetic research, and an intensified emphasis on personalized medicine. In the forecast period, key developments include improvements in diagnostic technologies, increased uptake of teleophthalmology, advanced technological treatments, product approvals, and the launch of new items.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21176&type=smp
What Core Drivers Are Expected To Influence The Dry Age Related Macular Degeneration (AMD) Market?
The upward trend in the elderly populace is set to fuel the expansion of the dry-age related macular degeneration (AMD) market. Older individuals, especially those above 65, comprise of the geriatric populace. Factors like medical technology enhancements, superior chronic illness management, augmented life expectancy, and superior older age attention contribute to the increasing elderly population. Therapy options and targeted treatments provided by Dry AMD are meant to slow the progression of diseases, conserve vision, and improve the life quality of the elderly affected by this condition. For example, a study publicized by the National Council on Aging, an organization in the US, in June 2024 showed about 57.8 million adults aged 65 and older in 2022. This population accounted for 17.3% of the total population of the U.S, indicating a rise from the previous 16.9% in 2021. Consequently, the increasing geriatric populace will be a significant driver in the expansion of the dry age-related macular degeneration (AMD) market.
Which Segmentation Categories Are Highlighted In The Dry Age Related Macular Degeneration (AMD) Market Analysis?
The dry age related macular degeneration (amd)market covered in this report is segmented –
1) By Stages: Early Age-Related Macular Degeneration; Intermediate Age-Related Macular Degeneration; Late Age-Related Macular Degeneration
2) By Age Group: Above 75 Years; Above 60 Years; Above 40 Years
3) By Route Of Administration: Oral; Injectables
4) By End Users: Hospitals And Clinics; Diagnostic Centers; Academic And Research Institutes
Subsegments:
1) By Early Age-Related Macular Degeneration: Drusen Accumulation; Retinal Pigment Epithelium Changes
2) By Intermediate Age-Related Macular Degeneration: Larger Drusen Deposits; Increased Pigmentary Abnormalities
3) By Late Age-Related Macular Degeneration: Geographic Atrophy; Central Vision Loss
Which Market Trends Are Expected To Define The Future Of The Dry Age Related Macular Degeneration (AMD) Market?
Top firms in the dry age-related macular degeneration (AMD) market are developing next-gen treatments like light delivery systems to slow disease progression by stimulating retinal cells. These systems use therapeutic light to support retinal health. In January 2024, US-based LumiThera Inc. launched the FDA-approved Valeda Light Delivery System for dry AMD. The system uses three wavelengths of light (590 nm, 660 nm, 850 nm) and is the first approved therapy for this condition. LumiThera also began the EUROLIGHT study to evaluate long-term patient outcomes.
Who Are The Dominant Players In The Dry Age Related Macular Degeneration (AMD) Market Today?
Major companies operating in the dry age related macular degeneration (AMD) market are F Hoffmann-La Roche Ltd., Novartis AG, Bayer AG, Amgen Inc., Biogen Inc., Astellas Pharma Inc., Bausch Health Companies Inc., Lupin Ltd., Santen Pharmaceuticals Inc., Biocon Ltd., Alimera Sciences Inc., Apellis Pharmaceuticals Inc., Belite Bio Inc., Axol Bioscience Ltd., Alkeus Pharmaceuticals Inc., Kubota Holdings Co., Ribomic Inc., Eyestem Research Pvt. Ltd., LumiThera Inc., Adverum Biotechnologies Inc.
Access The Complete Report Here:
Which Regional Markets Are Emerging As Key Hubs For The Dry Age Related Macular Degeneration (AMD) Market?
North America was the largest region in the dry age-related macular degeneration (AMD) market in 2024. The regions covered in the dry age related macular degeneration (AMD) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=21176&type=smp
Browse Through More Reports Similar to the Global Dry Age Related Macular Degeneration (AMD) Market 2025, By The Business Research Company
Macular Degeneration Treatment Global Market Report 2025
Age Related Macular Degeneration Global Market Report 2025
Cartilage Degeneration Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/cartilage-degeneration-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
